Stable RNA nanoparticles as potential new generation drugs for cancer therapy. - Wikidata - awgldk - TriplyDB

Stable RNA nanoparticles as potential new generation drugs for cancer therapy.

Stable RNA nanoparticles as potential new generation drugs for cancer therapy.

http://www.wikidata.org/entity/Q37640468

about

MicroRNAs in the DNA Damage/Repair Network and Cancer The Role of MicroRNAs in Diabetic Complications-Special Emphasis on Wound Healing NANOMEDICINE: will it offer possibilities to overcome multiple drug resistance in cancer?In silico design and enzymatic synthesis of functional RNA nanoparticles.Cell-type-specific, Aptamer-functionalized Agents for Targeted Disease Therapy Multifunctional RNA nanoparticles.Development of dual-activity vectors by co-envelopment of adenovirus and SiRNA in artificial lipid bilayers.Triggering of RNA interference with RNA-RNA, RNA-DNA, and DNA-RNA nanoparticles.Combinatorial library strategies for synthesis of cationic lipid-like nanoparticles and their potential medical applications.Innovative delivery of siRNA to solid tumors by super carbonate apatite.CD22ΔE12 as a molecular target for RNAi therapy.Human Papillomavirus E6/E7-Specific siRNA Potentiates the Effect of Radiotherapy for Cervical Cancer in Vitro and in Vivo RNA Nanoparticles Derived from Three-Way Junction of Phi29 Motor pRNA Are Resistant to I-125 and Cs-131 Radiation.Thermodynamic Features of Structural Motifs Formed by β-L-RNA RNA nanoparticle as a vector for targeted siRNA delivery into glioblastoma mouse model.Extracellular vesicles and their synthetic analogues in aging and age-associated brain diseases.Bolaamphiphiles as carriers for siRNA delivery: From chemical syntheses to practical applications RNA as a stable polymer to build controllable and defined nanostructures for material and biomedical applications Systemic Delivery of Anti-miRNA for Suppression of Triple Negative Breast Cancer Utilizing RNA Nanotechnology.A Multi-RNAi Microsponge Platform for Simultaneous Controlled Delivery of Multiple Small Interfering RNAs Re-entrant DNA gels.Delivery and targeting of miRNAs for treating liver fibrosis.MicroRNAs in cancer therapeutic response: Friend and foe Aptamers as targeted therapeutics: current potential and challenges.Nanocarriers for delivery of siRNA and co-delivery of siRNA and other therapeutic agents.RNA nanoparticles harboring annexin A2 aptamer can target ovarian cancer for tumor-specific doxorubicin delivery.Specific Delivery of MiRNA for High Efficient Inhibition of Prostate Cancer by RNA Nanotechnology.Controllable self-assembly of RNA dendrimers Co-delivery of siRNA and hypericin into cancer cells by hyaluronic acid modified PLGA-PEI nanoparticles.A high-throughput screening assay for the functional delivery of splice-switching oligonucleotides in human melanoma cells.siRNA nanoparticles: the future of RNAi therapeutics for oncology?Post-transcriptional regulation of cytokine and growth factor signaling in cancer.Advancement of the Emerging Field of RNA Nanotechnology.Engineering Structurally Interacting RNA (sxRNA).Mechanism of three-component collision to produce ultrastable pRNA three-way junction of Phi29 DNA-packaging motor by kinetic assessment.Controllable Self-Assembly of RNA Tetrahedrons with Precise Shape and Size for Cancer Targeting.Dual Tumor-Targeting Nanocarrier System for siRNA Delivery Based on pRNA and Modified Chitosan.Targeted nanoparticles for colorectal cancer.RNA Nanoparticle-Based Targeted Therapy for Glioblastoma through Inhibition of Oncogenic miR-21.Size, Shape, and Sequence-Dependent Immunogenicity of RNA Nanoparticles.

P2860

Q21284509-DBE6DBBE-D6B7-48B5-9289-732860622DF8 Q26827627-3B169F86-1A6C-415C-AE80-E84E03CC80CB Q28078448-01BCF5E1-BD72-4340-9704-9E0345EF549C Q33791733-05F7211A-2198-47B2-9913-B4F4BC24FD41 Q33834772-7AF76CFB-0ECF-42E7-9339-0F38A5265EF5 Q34306130-D55067C3-5A22-4ED2-ADB3-C6771EB03C71 Q34690551-A4710E36-DD0E-44C6-8898-E1C8897E62AB Q35027155-DEB76B05-66F6-4E48-A671-94FC7F62E9EE Q35568750-2B2BFE36-B3C8-4724-A45F-4F3130386AEC Q35571504-89CF77F4-DA6C-42EA-91E4-87CB0AB72981 Q35801180-D6691611-45A9-4A7F-B3F6-2EA7E12B5657 Q35813800-7E760A40-6811-434C-845C-A2281C16AB10 Q35866025-5AD8EA31-9CCE-4239-A820-3D66959E4947 Q35933327-9317CEC2-3529-459E-89B7-48A0F41FC13F Q36020835-7E0E32FA-CE56-4C1B-A06A-1480954F9211 Q36081720-D9DA4DD0-FD8E-41C1-A695-5654EC0AAE28 Q36426398-E0848805-3E60-46E8-B07D-070B3FD8DA9F Q36449335-931DD61A-FD4B-4B86-B623-101E382690A0 Q36490744-4990865A-AB34-4E8A-AD59-0C6E34F6EC6C Q36622859-A19C08DC-59B1-48CE-B97B-2902219C208A Q37363821-958740DF-742E-4425-AF04-A3D306E4045E Q38245905-E98DA340-944C-4268-8B4A-B0E3773A429D Q38258754-F0C5CB44-BE7E-41A5-BCED-2AE54187BEDA Q38290290-8A0ED903-2242-41B6-84E9-8B9C4468C848 Q38555082-F3112DED-45D0-4617-BF38-EC4824BB8A1B Q38728680-5EA30FA5-0A9A-4372-B9A1-9D6363A7627D Q38774730-2B48092A-9C44-4695-84E3-BC6C66F0A371 Q38812570-9CA125D1-E1F8-4C49-8C53-D12E7D7D9FC7 Q38827570-FD6AE133-BB3E-4453-B0F7-653F29174C5B Q38884283-50020BE1-89F1-472E-88CF-56A4766E74A1 Q38938368-CF031562-EFE0-4F02-9455-1F35AAB93BF5 Q39036700-0E25FD84-4306-42FD-8D9C-7DAB781DDC75 Q39065708-C8E749FA-9B43-4B8E-898D-DFA6B1241800 Q40275395-334986D0-11B4-4733-B132-790336630231 Q40564594-5E619E4C-40AC-4EEB-8687-C3805082F47E Q41432210-7B6148C0-BB86-4D4F-9FFE-6DF54B6A444C Q41646988-81C01E6C-C7A2-4278-84A6-87A71E5D4CD8 Q42365964-48452E8E-D375-4906-86CA-0F8A2A35C389 Q45863841-65A63D03-E93D-4C14-A40C-8BBCFE19AA8D Q47097375-E189752A-4145-4C50-844B-E9C6F030EA57

P2860

Stable RNA nanoparticles as potential new generation drugs for cancer therapy.

http://www.wikidata.org/entity/Q37640468

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年学术文章

@wuu

2013年学术文章

@zh-cn

2013年学术文章

@zh-hans

2013年学术文章

@zh-my

2013年学术文章

@zh-sg

2013年學術文章

@yue

2013年學術文章

@zh

2013年學術文章

@zh-hant

name

Stable RNA nanoparticles as potential new generation drugs for cancer therapy.

@en

Stable RNA nanoparticles as potential new generation drugs for cancer therapy.

@nl

type

label

Stable RNA nanoparticles as potential new generation drugs for cancer therapy.

@en

Stable RNA nanoparticles as potential new generation drugs for cancer therapy.

@nl

prefLabel

Stable RNA nanoparticles as potential new generation drugs for cancer therapy.

@en

Stable RNA nanoparticles as potential new generation drugs for cancer therapy.

@nl

P1433

Q37640468-F4D56E6D-4A11-4802-90D3-5D5A17C830EE

P1476

Q37640468-4E2888B5-BDF5-4E3A-8FC2-C830158DD7CF

P2093

Q37640468-1ACC5483-395E-4DBA-9D25-3713FEF8D812

Q37640468-2129500D-04AD-4613-9BDA-D29AC9AE20A6

Q37640468-600C88DE-52CD-43A8-98A3-3004CB894D2A

Q37640468-6C622B4B-4F59-4036-93A2-DC632AD3A774

Q37640468-8553FB22-B905-40DE-89D5-15D693E5D667

Q37640468-9747B5B8-FFEF-491F-BCAB-9825E544A2DF

Q37640468-A9D0647D-74F1-4473-B485-E60DCCD0ACD6

Q37640468-AEA70799-B2F5-49F3-9561-6656F80674F1

P2860

Q37640468-0031BC0A-0163-426E-99B0-A9DCFAA198CE

Q37640468-00BAFB15-A1F0-4972-87E1-F045A0B371C9

Q37640468-01B745DE-4615-4D9A-82A1-EC4132805EF5

Q37640468-035B4B15-A1CC-4F16-824B-5A3D4AB08E42

Q37640468-05037780-97B0-4A6D-A386-2A363D0C2EEB

Q37640468-05D0189D-A657-46E8-ABA7-9F1D8B5F2127

Q37640468-06E00ED4-324B-47A9-AC65-1E1D135106DB

Q37640468-075CCBE2-1FF3-4B41-A4EA-E77B089A38C3

Q37640468-07B7E1E5-EFA3-44E6-9BFE-C2056DA524C2

Q37640468-08DA8AD2-754B-4337-A7D9-C464B7CC34E4

P304

Q37640468-1B2F7D51-08B4-42D5-86E5-1430E332A03A

P31

Q37640468-BBEFAFBF-B560-45B2-A1D2-FD470C234985

P356

Q37640468-812DF414-A8B4-419C-9AEF-C71980F6431F

P407

Q37640468-AE5DF651-0E89-4A4F-8BA6-052A94A8C8F4

P478

Q37640468-5929FD28-8B6E-4C16-9F70-D774A507615D

P50

Q37640468-466DBFD5-7A99-41CD-A5AF-7902A7C77347

P577

Q37640468-E2886101-262A-4F57-B9CC-3E9191BF8D91

P5875

Q37640468-E919A129-A811-4735-97B0-490181E49D78

P698

Q37640468-52B6817F-263E-418E-8077-C30F1A5398BF

P921

Q37640468-ADD7179F-A135-4003-90A7-A287654289F4

P932

Q37640468-DEDBBEFC-8FF2-4345-85BE-5FA18948B5C0

P356

J.ADDR.2013.11.006

P1433

Advanced Drug Delivery Reviews

P1476

Stable RNA nanoparticles as potential new generation drugs for cancer therapy.

@en

P2093

B Mark Evers

http://www.w3.org/2001/XMLSchema#string

Dan Shu

http://www.w3.org/2001/XMLSchema#string

Farzin Haque

http://www.w3.org/2001/XMLSchema#string

Fengmei Pi

http://www.w3.org/2001/XMLSchema#string

Markos Leggas

http://www.w3.org/2001/XMLSchema#string

Mehdi Rajabi

http://www.w3.org/2001/XMLSchema#string

Peixuan Guo

http://www.w3.org/2001/XMLSchema#string

Yi Shu

http://www.w3.org/2001/XMLSchema#string

P2860

Initial sequencing and analysis of the human genome

Small nucleolar RNA signatures as biomarkers for non-small-cell lung cancer

Assembling Materials with DNA as the Guide

Self-assembly of a nanoscale DNA box with a controllable lid

Folding DNA to create nanoscale shapes and patterns

Mfold web server for nucleic acid folding and hybridization prediction

Sfold web server for statistical folding and rational design of nucleic acids

Molecular robots guided by prescriptive landscapes.

The emerging field of RNA nanotechnology

Targeted deletion of Dicer in the heart leads to dilated cardiomyopathy and heart failure

P304

74-89

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.ADDR.2013.11.006

http://www.w3.org/2001/XMLSchema#string

P407

P478

66

http://www.w3.org/2001/XMLSchema#string

P50

Ashwani K Sharma

P577

2013-11-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

258853886

http://www.w3.org/2001/XMLSchema#string

P698

24270010

http://www.w3.org/2001/XMLSchema#string

P921

P932

3955949

http://www.w3.org/2001/XMLSchema#string